Literature DB >> 21744182

Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events.

Sara Pereira da Silva1, Elena Resnick, Mary Lucas, Jennifer Lortan, Smita Patel, Charlotte Cunningham-Rundles, Kevin Gatter, Qingyan Liu, Elaine S Jaffe, Helen Chapel.   

Abstract

Patients with common variable immunodeficiency disorders (CVIDs) who developed B cell lymphoproliferation of indeterminate malignant potential are described in order to raise a discussion of the relationship between infection and lymphoproliferation in infection prone patients. Those with CVID are at risk of developing either polyclonal or monoclonal lymphoproliferation in part due to the dysregulation of their adaptive immune systems. The aetiologies of the lymphoproliferations are unknown but intriguing; the relevance of infection being particularly problematic. The patients described here demonstrate variability in preceding infection, age at presentation, response to antibiotics and other types of therapy as well as outcome. The question of treatment is also controversial; issues include whether antibiotics or chemotherapy are the first line of therapy in all patients and whether transformation to aggressive B cell malignancy is inevitable or depends on other factors and if so, the length of time for such progression.

Entities:  

Mesh:

Year:  2011        PMID: 21744182      PMCID: PMC3428024          DOI: 10.1007/s10875-011-9565-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Genome-wide association identifies diverse causes of common variable immunodeficiency.

Authors:  Jordan S Orange; Joseph T Glessner; Elena Resnick; Kathleen E Sullivan; Mary Lucas; Berne Ferry; Cecilia E Kim; Cuiping Hou; Fengxiang Wang; Rosetta Chiavacci; Subra Kugathasan; John W Sleasman; Robert Baldassano; Elena E Perez; Helen Chapel; Charlotte Cunningham-Rundles; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

Authors:  Mary Lucas; Martin Lee; Jenny Lortan; Eduardo Lopez-Granados; Siraj Misbah; Helen Chapel
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

3.  Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect.

Authors:  Marion Malphettes; Laurence Gérard; Maryvonnick Carmagnat; Gaël Mouillot; Nicolas Vince; David Boutboul; Alice Bérezné; Raphaële Nove-Josserand; Vincent Lemoing; Laurent Tetu; Jean-François Viallard; Bernard Bonnotte; Michel Pavic; Julien Haroche; Claire Larroche; Jean-Claude Brouet; Jean-Paul Fermand; Claire Rabian; Claire Fieschi; Eric Oksenhendler
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

4.  Dissecting the group of common variable immunodeficiency disorders.

Authors:  Aamir Aslam; Helen Chapel
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

5.  Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.

Authors:  H Liu; A Ruskon-Fourmestraux; A Lavergne-Slove; H Ye; T Molina; Y Bouhnik; R A Hamoudi; T C Diss; A Dogan; F Megraud; J C Rambaud; M Q Du; P G Isaacson
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

6.  EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?

Authors:  Sarah E Gibson; Steven H Swerdlow; Fiona E Craig; Urvashi Surti; James R Cook; Michael A Nalesnik; Chris Lowe; Katrina M Wood; Chris M Bacon
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

7.  Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?

Authors:  Claire M Vajdic; Limin Mao; Marina T van Leeuwen; Philippa Kirkpatrick; Andrew E Grulich; Sean Riminton
Journal:  Blood       Date:  2010-05-13       Impact factor: 22.113

8.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

9.  The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  Mod Pathol       Date:  2000-02       Impact factor: 7.842

Review 10.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

View more
  22 in total

1.  Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.

Authors:  Paul J Maglione; Jessica R Overbey; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2015-09-12

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Multiple malignancies in a female patient with common variable immunodeficiency syndrome.

Authors:  Milena Todorovic; Bela Balint; Bosko Andjelic; Biljana Mihaljevic
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

4.  Myelodysplastic Syndrome and Acute Lymphocytic Leukemia in Common Variable Immunodeficiency (CVID).

Authors:  Jennifer Toh; Rachel Eisenberg; Kamila Bakirhan; Amit Verma; Arye Rubinstein
Journal:  J Clin Immunol       Date:  2016-03-18       Impact factor: 8.317

5.  Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.

Authors:  Monica Piquer Gibert; Laia Alsina; María Teresa Giner Muñoz; Ofelia Cruz Martínez; Karen Ruiz Echevarria; Olga Dominguez; Ana María Plaza Martín; Juan I Arostegui; Guillem de Valles; Manel Juan Otero; Maria Anunciacion Martin-Mateos
Journal:  Eur J Pediatr       Date:  2015-03-10       Impact factor: 3.183

Review 6.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 7.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

Review 8.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

9.  [Common variable immunodeficiency: a clinical challenge].

Authors:  K Warnatz; S Goldacker
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

Review 10.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.